Efficacy and Safety of Rituximab in Antiglomerular Basement Membrane Disease
Acknowledging the limitations of our study, including publication and selection bias, rituximab had a favorable toxicity and efficacy profile. The results indicate that rituximab can be considered as a second-line therapy in anti-GBM disease when cyclophosphamide is contraindicated.
Authors
- Andreas Kronbichler (ORCID: https://orcid.org/0000-0002-2945-2946)
- Annette Bruchfeld (ORCID: https://orcid.org/0000-0002-9752-9941)
- Ajay Jaryal (ORCID: https://orcid.org/0000-0002-4411-6350)
- Maxime Touzot (ORCID: https://orcid.org/0000-0002-0510-2431)
- Mårten Segelmark (ORCID: https://orcid.org/0000-0002-1221-0772)
- Georgina Maalouf (ORCID: https://orcid.org/0000-0002-4554-1922)
- Richard Klaus (ORCID: https://orcid.org/0000-0002-2234-4248)
- Dieter Haffner (ORCID: https://orcid.org/0000-0002-9601-7813)
- Sanjay Vikrant (ORCID: https://orcid.org/0000-0003-2527-0384)
- Stephen P. McAdoo (ORCID: https://orcid.org/0000-0001-8260-8770)
- Bärbel Lange-Sperandio (ORCID: https://orcid.org/0000-0001-8898-3459)
- Ingeborg M. Bajema
- David Saadoun (ORCID: https://orcid.org/0000-0003-3628-9996)
- Nele Kanzelmeyer (ORCID: https://orcid.org/0000-0002-4865-4906)
- Vanja Ivković (ORCID: https://orcid.org/0000-0001-9642-4075)
- Asheesh Kumar (ORCID: https://orcid.org/0000-0002-0592-0629)
Institutions
- Linköping University (SE)
- University Medical Center Groningen (NL)
- Karolinska University Hospital (SE)
- Innsbruck Medical University (AT)
- Imperial College Healthcare NHS Trust (GB)
- University of Rijeka (HR)
- Inserm (FR)
- Lund University (SE)
- Hammersmith Hospital (GB)
- LMU Klinikum (DE)
- Medizinische Hochschule Hannover (DE)
- Sorbonne Université (FR)
- Centre de Référence des Maladies Autoinflammatoires et des Amyloses (FR)
- Skåne University Hospital (SE)
- Association pour l'Utilisation du Rein Artificiel (FR)
- Immunologie - Immunopathologie - Immunothérapie (FR)
- Imperial College London (GB)
- All India Institute of Medical Sciences (IN)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1016/j.ekir.2024.12.026
- Citations
- 3
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 1.26